Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Rossari Biotech Ltd - 543213 - Board Meeting Intimation for Audited Financial Statements And Financial Results (Standalone And Consolidated) For The Quarter And Financial Year Ended 31St March, 2024 And Recommendation Of Final Dividend.

 Rossari Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/04/2024 ,inter alia, to consider and approve Audited Financial Statements and Financial Results (Standalone and Consolidated) for the quarter and financial year ended 31st March, 2024 and recommend payment of Final Dividend for the Financial Year ended 31.03.2024.
20-04-2024
Bigul

Rossari Biotech Ltd - 543213 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

 Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyRossari Biotech Ltd 2CIN NO.L24100MH2009PLC194818 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 54.92 4Highest Credit Rating during the previous FY AA- 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)ICRA LIMITED 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Parul Gupta Designation: Company Secretary and Compliance Officer EmailId: [email protected] Name of the Chief Financial Officer: Ketan Sablok Designation: Group Chief Financial Officer EmailId: [email protected] Date: 12/04/2024 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
12-04-2024
Bigul

Rossari Biotech Ltd - 543213 - Board Meeting Outcome for Outcome Of The Board Meeting Held On April 06, 2024

 The Board of Directors have inter alia approved Incorporation of wholly owned subsidiary in Dubai, United Arab Emirates and Appointment of Mr. Sunil V as Chief Human Resource Officer and other matters.
06-04-2024
Bigul

Rossari Biotech Ltd - 543213 - Compliance Certificate Pursuant To Regulation 40(10)

 Compliance Certificate issued by Mr. Sanjay Dholakia of Sanjay Dholakia & Associates, Practicing Company Secretaries, for the period April 01, 2023 to March 31, 2024.
05-04-2024
Bigul

Rossari Biotech Ltd - 543213 - Compliance Certificate Under Regulation 7(3) Of SEBI (Listing And Disclosure Requirements) Regulations, 2015 For The Year Ended March 31, 2024.

 Compliance certificate under Regulation 7(3) of SEBI(Listing and Disclosure Requirements) Regulations, 2015 for the year ended March 31, 2024.
04-04-2024
Bigul

Rossari Biotech Ltd - 543213 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Compliance certificate under Regulation 74(5) of SEBI (Depository and Participants) Regulations, 2018 for the quarter ended March 31, 2024.
04-04-2024
Bigul

Rossari Biotech Ltd - 543213 - Closure of Trading Window

 Intimation of Trading Window Closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.
26-03-2024
Bigul

Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Intimation of Analyst/Institutional Investor Meet/Con. Call/Updates.
07-02-2024
Bigul

Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

 Intimation of Transcript of Q3 FY 24 for the Earnings Conference Call held on 23 January, 2024.
30-01-2024

Buy Rossari Biotech; target of Rs 925: KR Choksey

 KR Choksey is bullish on Rossari Biotech has recommended buy rating on the stock with a target price of Rs 925 in its research report dated January 25, 2024.
29-01-2024
Next Page
Close

Let's Open Free Demat Account